Thursday, October 10, 2019

Time To Address How Justice Is Dispensed To Foster Children - Not One Penny Of $8 Billion Risperdal Settlement Will Go To Medicaid Billed Foster Kids Who Were Lab Rats

FUN FACT! REISPERDAL WAS TESTED ON FOSTER KIDS AS LAB RATS

ANOTHER FUN FACT! WHEN FOSTER BOYS WOULD GROW BREASTS, THEY WERE PRESCRIBED MORE SECOND GENERATION ANTIPSYCHOTROPICS TO STOP THE BREAST GROWTH

Just think.

Arnold & Itkin LLP
Arnold & Itkin
Not one foster boy who was used as a lab rat and grew breasts will receive one red penny.

Not a dime.

Not even allowed access to their medical records upon aging out or escaping of foster care to a life on the streets, with breasts.

Why, you may ask?

Because no one cares and the attorneys will get the largest chunk of the damages, with the States in tow, launching more foreign Social Impact Bond programs, for more socioeconomic experiments, to their Public Private Partnerships, to fund campaigns.

I called Arnold & Itkin to ask if any foster kids would receive part of the settlement, or if the firm is going to work with the States Medicaid Fraud Control Units, but was told that the settlement was for their client.

One person, where not one penny goes to the Foster Kids who were used as lab rats, where the illegal use of Risperdal was billed to Medicaid, where not one penny will be reimbursed to the States.

The law firm did take my information and said they would call me back.

They asked with whom I was working.

I informed them that I would be reporting to the U.S. Department of Justice, who can then refer to the proper conjugal collaboration, just as soon as I publish.

Oh, and if a parent lodges a formal complaint, they are met with threats of termination of parental rights, to put the boy up for adoption to be sold, and continue being drugged above and beyond adult dosages.

Will the States Medicaid Fraud Control Units do anything?

Utah Attorney General Mark Schurtleff did, where his original complaint is below, but it seemed to get rather murky, and it seems to be ongoing.

Everything you wanted to know about Risperdal and foster kids if here.

Here is everything you wanted to know about drugging foster kids as lab rats - antipsychotropic experiments.

It is time to address how justice is dispensed to Foster Children.

Just keeping it real.

Johnson & Johnson to pay $8B in damages for Risperdal drug linked to female breast tissue in boys

Johnson & Johnson to pay $8B in damages for Risperdal drug linked to female breast tissue in boys

A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys.

Image result for johnson and johnson
Risperdal
PHILADELPHIA (AP) - A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys.

Johnson and Johnson immediately denounced the award after the jury's decision in the Court of Common pleas, saying it's "excessive and unfounded" and vowing immediate action to overturn it.

The antipsychotic drug Risperdal is at the center of the lawsuit, with the plaintiff's attorneys arguing it's linked to abnormal growth of female breast tissue in boys, an incurable condition known as gynecomastia.

Johnson & Johnson used an organized scheme to make billions of dollars while illegally marketing and promoting the drug, attorneys Tom Kline and Jason Itkin said in a statement.

Johnson & Johnson said in a statement on its website it was confident that the award would be overturned, calling it "grossly disproportionate" with the initial compensatory damage award and "a clear violation of due process."

Johnson & Johnson said the court's exclusion of key evidence left it unable to present a meaningful defense, including what they said was a drug label that "clearly and appropriately outlined the risks associated with the medicine" or Risperdal's benefits for patients with serious mental illness. They also said the plaintiff's attorneys failed to present any evidence of actual harm.

"This decision is inconsistent with multiple determinations outside of Philadelphia regarding the adequacy of the Risperdal labeling, the medicine's efficacy, and findings in support of the company," Johnson & Johnson said. "We will be immediately moving to set aside this excessive and unfounded verdict."

Utah AG Attacks Medicaid Fraud


Voting is beautiful, be beautiful ~ vote.©

No comments: